dr. nastoupil on pembrolizumab plus rituximab in relapsed follicular lymphoma
Published 7 years ago • 318 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
1:58
dr. nastoupil on efficacy with pembrolizumab and rituximab in follicular lymphoma
-
2:49
prof: loretta nastoupil - pembrolizumab and rituximab in r/r fl
-
1:31
dr. leonard on lenalidomide with rituximab in follicular lymphoma
-
1:58
dr. andorsky on the magnify trial in follicular lymphoma
-
5:45
maintenance therapy outcomes in follicular lymphoma
-
1:26
dr. nastoupil on future treatment approaches in large cell lymphoma
-
6:15
therapy for relapsed follicular lymphoma
-
1:00
dr. andorsky on next steps following magnify trial in follicular lymphoma
-
3:53
ash 2019 interview - dr loretta nastoupil - follicular lymphoma (part 1)
-
58:11
follicular lymphoma: changes in the treatment landscape
-
1:13
dr. nastoupil on triplet of tgr1202, ublituximab, and ibrutinib in cll
-
1:25
targeted therapy for the treatment of follicular lymphoma
-
4:16
asst. prof. loretta nastoupil | ash 2017 | added value of checkpoint inhibitors in relapsed fl
-
1:16
dr. lacasce discusses the fda approval of lenalidomide/rituximab in non-hodgkin lymphoma
-
4:54
diagnosis and prognosis of follicular lymphoma
-
2:30
dr nowakowski on the epcore nhl-1 trial results of epcoritamab in r/r follicular lymphoma
-
1:23
dr. burtness on the benefit of pembrolizumab in head and neck cancer
-
1:26
dr. nastoupil on questions surrounding tgr1202 in patients with cll
-
6:39
immunotherapy in the treatment of follicular lymphoma